Levofloxacin Tablet, Film Coated
Product Images NDC 61919-426

2 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 61919-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

426 07

426 07
Packaging label for LEVOFLOXACIN 500 mg tablets, containing 7 tablets per bottle. The label specifies it as a generic for LEVAQUIN, with each film-coated tablet containing 500 mg of levofloxacin USP. The product is packaged and distributed by Direct Rx in Alpharetta, GA. The label includes lot number, expiration date (Discard After 05/19), and NDC 61919-426-07.*
FDA Label Image

440-14 (440 14)

440-14 (440 14)
Label for LEVOFLOXACIN 750 mg tablets, containing 14 tablets per package. The label states it is a generic for LEVAQUIN with the active ingredient levofloxacin USP 750 mg. Manufactured by Cipla USA Inc., Miami, FL, and distributed by Direct Rx, Alpharetta, GA. The label includes lot number, expiration date, NDC 69997-287-81, and a caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.